ClinicalTrials.Veeva

Menu

Subantimicrobial Doxycycline in Acne

Michigan State University logo

Michigan State University

Status and phase

Completed
Phase 4

Conditions

Pediatrics
Acne Vulgaris

Treatments

Drug: Doxycycline Hyclate

Study type

Interventional

Funder types

Other

Identifiers

NCT05399290
STUDY00003269

Details and patient eligibility

About

Antibiotic resistance is a public health problem that worsens the more physicians prescribe standard dose antibiotics for acne. Regardless of race, acne vulgaris is one of the most common dermatologic conditions among pediatric populations. As such, clinicians can make a large impact by practicing good antibiotic stewardship while still addressing the impact of acne on adolescents' self-esteem. Subantimicrobial doxycycline maintains its anti-inflammatory effects while eliminating antimicrobial properties and associated risks of drug resistance. Few studies, focused primarily on adults, have shown that subantimicrobial doxycycline is efficacious in treating acne from a physician standpoint. The investigators aim to investigate the patient experience of acne treatment with subantimicrobial dose doxycycline in the pediatric population.

Enrollment

22 patients

Sex

All

Ages

13 to 17 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Documented moderate to severe facial acne

Exclusion criteria

  • Other skin conditions on the face
  • Previous antibiotic treatment for acne
  • Use of antibiotics for any reason within the past month
  • Use of new prescription regiment for acne within the last 3 months
  • Positive pregnancy test in the clinic
  • Cognitive impairments

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

22 participants in 2 patient groups

100 mg standard dose doxycycline BID
Active Comparator group
Description:
Oral, 12 weeks
Treatment:
Drug: Doxycycline Hyclate
20 mg sub-antimicrobial dose doxycycline BID
Experimental group
Description:
Oral, 12 weeks
Treatment:
Drug: Doxycycline Hyclate

Trial documents
1

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems